• LY364947: TGF-β Type I Receptor Kinase Inhibitor in EMT & Fi

  2026-05-28

  LY364947 empowers researchers to dissect and modulate TGF-β-driven processes with precision, supporting advanced EMT, fibrosis, and retinal degeneration studies. This guide delivers actionable protocols, troubleshooting insights, and context from the latest pathway crosstalk research to maximize the impact of LY364947 in preclinical workflows.

• Optimizing Cell Viability Assessment: Translational Insights

  2026-05-28

  This thought-leadership article explores how advanced live-dead cell staining — specifically dual Calcein-AM and Propidium Iodide assays — is revolutionizing translational research in wound healing and biomaterials, bridging mechanistic understanding with actionable protocol guidance. It contextualizes the APExBIO Live-Dead Cell Staining Kit within the latest advances in diabetic wound therapy, comparing its precision and robustness to traditional methods, and offers strategic guidance for researchers seeking to maximize reproducibility and clinical relevance.

• Reliable Native Protein Gel Electrophoresis with Kit K4142

  2026-05-27

  This article delivers a scenario-driven, evidence-based guide to resolving common challenges in native protein gel electrophoresis for acidic proteins. Emphasizing the reproducibility and practical advantages of the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) (SKU K4142), it equips biomedical researchers and lab technicians with actionable insights for preserving native protein structure, enhancing data integrity, and streamlining experimental workflows.

• Fasudil (HA-1077) HCl: ROCK Inhibition Meets Hippo Pathway I

  2026-05-27

  Discover how Fasudil (HA-1077) HCl, a selective ROCK inhibitor, enables advanced research on cell proliferation and apoptosis by bridging Rho/ROCK and Hippo pathway biology. Explore mechanistic depth, assay optimization, and new translational avenues for cancer and lens research.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-26

  This study presents a nanoparticle system for systemic delivery of PTEN mRNA, effectively overcoming trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN expression and suppressing PI3K/Akt signaling, the approach offers a promising strategy for enhancing monoclonal antibody therapy efficacy.

• Methylation Pathways in Neurological Disorders: SAMe and Bey

  2026-05-26

  This review synthesizes evidence on the role of ademetionine (S-adenosylmethionine, SAMe) in methylation-dependent pathways relevant to neurological and psychiatric disorders. It details the mechanistic links between methyl group metabolism, neurotransmitter dynamics, and clinical outcomes, offering context for targeted intervention strategies in neuropsychiatric research.

• Molidustat (BAY85-3934): Reliable HIF-PH Inhibition for Viab

  2026-05-25

  This article provides an authoritative, scenario-driven guide for deploying Molidustat (BAY85-3934) (SKU B5861) in cell viability and proliferation assays. By addressing common laboratory challenges and supporting recommendations with peer-reviewed evidence, it demonstrates how this HIF-PH inhibitor from APExBIO ensures reproducibility and mechanistic clarity for hypoxia pathway research.

• GDC-0941: Redefining PI3K Inhibition for Resistant Cancer Mo

  2026-05-25

  Explore how GDC-0941, a selective PI3K inhibitor, enables precise dissection of the PI3K/Akt pathway in therapy-resistant cancer models. This article provides advanced workflow guidance, comparative insights, and practical assay recommendations for translational oncology research.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Protocols &

  2026-05-24

  The JC-1 Mitochondrial Membrane Potential Assay Kit empowers researchers to quantify mitochondrial health and apoptosis dynamics with ratiometric precision. Discover advanced workflow strategies, troubleshooting insights, and how recent immunomodulatory breakthroughs shape practical assay design.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-05-23

  Lyso-Tracker Red is a high-specificity fluorescent lysosome probe for live cell imaging, enabling robust visualization of intracellular acidic compartments. Its selective accumulation and red fluorescence support advanced analysis of lysosomal distribution and function. The probe is supplied by APExBIO and is a benchmark reagent in cell biology research.

• Myriocin in Sphingolipid Metabolism: Beyond Inhibition to Ce

  2026-05-22

  Explore how Myriocin, a potent serine palmitoyltransferase inhibitor, advances sphingolipid metabolism research and cell cycle regulation. This article uniquely bridges mechanistic insights with emerging mitochondrial and cellular aging paradigms.

• Curcumol Drives Necroptosis in Hepatic Stellate Cells via KA

  2026-05-22

  This study uncovers how Curcumol targets the KAT8–HK2–lactylation pathway to induce necroptosis in hepatic stellate cells, thereby reducing liver fibrosis. These findings highlight a novel metabolic vulnerability for therapeutic intervention in fibrotic liver disease.

• Metabolomics Distinguishes Carbapenemase-Producing Enterobac

  2026-05-21

  This study leverages LC-MS/MS metabolomics to rapidly differentiate carbapenemase-producing Enterobacterales from non-resistant strains based on distinct metabolic signatures. The findings highlight a panel of metabolic biomarkers and pathway disruptions, offering a foundation for faster diagnostics and deeper mechanistic insight into antibiotic resistance.

• Coronavirus Macrodomains Counteract PARP-Mediated Antiviral

  2026-05-21

  Grunewald et al. (2019) reveal that the coronavirus macrodomain is essential for evading host poly(ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and for modulating interferon responses. This study identifies PARP12 and PARP14 as key antiviral effectors, highlighting new mechanistic insights into virus-host interactions and suggesting potential targets for antiviral strategies.

• Perospirone Inhibits Vascular Kv1.5 Channels: Cardiovascular

  2026-05-20

  A recent study identifies perospirone, an atypical antipsychotic, as a direct inhibitor of vascular Kv1.5 channels in coronary arterial smooth muscle cells. This finding extends the pharmacological understanding of perospirone beyond its classical receptor targets and highlights potential cardiovascular considerations relevant for translational research.

15270 records 1/1018 page Next 12345 下5页 Last page